"Reproductive Genetic Innovations is a world-renowned pioneer of Preimplantation Genetic Testing. With experience spanning three decades, RGI has mastered PGT technologies and currently performs genetic testing for single-gene disorders, translocations, and aneuploidies. RGI also offers genetic counseling, on-site IVF lab services, traveling embryology, and POC testing to affiliated clinics and referred patients."

During the past decade, Reproductive Genetics Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Reproductive Genetics Institute" #1 collaborator was "PRA Health Sciences" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Reproductive Genetics Institute" are "Down Syndrome" (2 trials), "Aneuploidy" (1 trials), "Edwards Syndrome" (1 trials), "Fetal Aneuploidy" (1 trials) and "Pregnancy" (1 trials). Many other conditions were trialed in "Reproductive Genetics Institute" in a lesser frequency.

The vast majority of trials in "Reproductive Genetics Institute" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Reproductive Genetics Institute". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Reproductive Genetics Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Reproductive Genetics Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".